Search Results 641-650 of 13330 for monoclonal antibody

1. Capecitabine And Bevacizumab With Or Without Atezolizumab In Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

   Monoclonal antibodies, such as atezolizumab and bevacizumab, may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy ...

2. A Study To Evaluate Firstline Pembrolizumab Alone Or In Combination With Pemetrexed And Carboplatin In Induction/Maintenance Or Postprogression In Treating Patients With Stage IV Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

3. Oncology (Medical) - Clinical trials

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

4. Medical Research & Education - Mayo Clinic News Network

   In a new study published in[...] Latest stories. Patients treated with monoclonal antibodies during COVID- ...

5. Rituximab With Or Without Stem Cell Transplant In Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma In First Complete Remission - Mayo Clinic

   Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell ...

6. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

7. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

8. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

9. Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers - Mayo Clinic

   Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2. This may restrain new blood vessel formation therefore ...

10. Trastuzumab-strf (intravenous route) - Side effects & uses - Mayo Clinic

    Trastuzumab-strf is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...